Home › Astigmatism › NCT07502456

Clareon TruPlus Study

Clareon TruPlus Single-Arm Study

Who can join

Ages 22 and older · All sexes

Key Inclusion Criteria:

* Diagnosed with bilateral cataracts and planned bilateral cataract extraction by routine phacoemulsification.
* Potential postoperative BCDVA of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator.
* Astigmatism suitable for correction with available toric IOL models.
* Other protocol-specified inclusion criteria may apply.

Key Exclusion Criteria:

* Age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and other eye conditions as specified in the protocol.
* Moderate to severe dry eye that would affect study measurements.
* Other protocol-specified exclusion criteria may apply.

About the study

The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed. IOLs are intended to remain in the eyes for the duration of the patient's lifetime.

What is being tested

• Clareon TruPlus Monofocal Non-Toric IOL (device)
• Clareon TruPlus Monofocal Toric IOL (device)
• Phacoemulsification (procedure)

Sponsor: Alcon Research · Participants: 122 · Started: May 26, 2026

Contact the study team

• Alcon Call Center · Phone: 1-888-451-3937

Official record on ClinicalTrials.gov — NCT07502456

Locations in the U.S.

Conditions

• Astigmatism
• Cataract

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.